BHI (083650) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
28 Jan, 2026Executive summary
The audit report expresses an unqualified (clean) opinion on the financial statements for the years ended December 31, 2024, and 2023, confirming fair presentation in accordance with Korean IFRS.
The internal control system was also found to be effective as of December 31, 2024.
Financial highlights
Revenue for 2024 was ₩399.2 billion, up from ₩352.3 billion in 2023 (13.3% year-over-year growth).
Operating income rose to ₩26.6 billion from ₩17.6 billion year-over-year.
Net income for 2024 was ₩24.3 billion, a significant increase from ₩7.5 billion in 2023.
Total assets increased to ₩522.5 billion at 2024 year-end from ₩423.2 billion at 2023 year-end.
Cash and cash equivalents at year-end were ₩10.3 billion, up from ₩8.2 billion.
Outlook and guidance
The company continues to recognize revenue over time using the input method for long-term contracts, with ongoing focus on contract cost estimation and progress measurement.
Management expects continued exposure to contract cost and revenue estimation uncertainties, which may impact future earnings.
Latest events from BHI
- Q1 2026 saw KRW 280.8B revenue, KRW 5.1B net income, and a 393% debt-to-equity ratio.083650
Q1 202624 Jun 2026 - Revenue down, profit up; major contract canceled, FX risk and asset revaluation notable.083650
Q2 202424 Jun 2026 - Net income rose on improved margins and asset revaluation, despite lower sales and a contract loss.083650
Q3 202424 Jun 2026 - Q1 2025 revenue reached KRW 135.3B, with strong HRSG sales and robust order backlog.083650
Q1 202524 Jun 2026 - Net income more than doubled on higher margins despite lower revenue, with a robust order backlog.083650
Q2 202524 Jun 2026 - Revenue and profit surged on export growth, with a robust order backlog supporting outlook.083650
Q3 202524 Jun 2026 - Revenue and net income surged on export growth and project gains, with robust order backlog.083650
Q4 20251 Apr 2026